Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment.

@article{Tanaka2013CharacterizationOF,
  title={Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment.},
  author={Yuriko Tanaka and Yoshiko Abe and Yuji Oto and Hisashi Itabashi and Masahisa Shiraishi and Atsunori Yoshino and Kazuo Obata and Nobuyuki Murakami and Toshiro Nagai},
  journal={American journal of medical genetics. Part A},
  year={2013},
  volume={161A 1},
  pages={27-33}
}
Marked anthropometric changes are seen in Prader-Willi syndrome (PWS). Emaciation is observed during infancy, whereas severe obesity is found in older children and adults. Growth hormone (GH) treatment modifies the anthropometric changes in PWS patients. In this study, we examined changes in the body composition of 51 PWS patients (age range, 6-54 years; median, 16.5 years), with a focus on the amount of abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT), VAT/SAT… CONTINUE READING